Nutra Pharma Corp (NPHC) EPS (Basic) (2011 - 2026)

Nutra Pharma has disclosed EPS (Basic) across 16 years of filings, most recently posting -$0.0 for Q2 2026.

• In Q2 2026, EPS (Basic) fell 1125.56% year-over-year to -$0.0; the TTM figure through Jun 2026 stood at -$0.0 (down 240.74% YoY), while the FY2025 annual figure was -$0.0, down 57.09% from the prior year.
• EPS (Basic) came in at -$0.0 for Q2 2026 at Nutra Pharma, down from -$0.0 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $0.0 in Q1 2022 to a low of -$0.0 in Q2 2026.
• Average EPS (Basic) over 5 years is -$0.0, with a median of -$0.0 recorded in 2023.
• Year-over-year, EPS (Basic) jumped 199.55% in 2025 and sank 1125.56% in 2026.
• Over 5 years, EPS (Basic) stood at $0.0 in 2022, then plunged by 107.26% to -$0.0 in 2023, then gained by 5.82% to -$0.0 in 2024, then sank by 108.71% to -$0.0 in 2025, then plunged by 679.44% to -$0.0 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were -$0.0 in Q2 2026, -$0.0 in Q1 2026, and -$0.0 in Q4 2025.